• Immunization & Child Profile Office
• For Schools and Parents
• Immunizations
• For Health Care Providers
• Vaccines
• Forms and Publications

• Department of Health Home
• Prevention & Community  Health
   

Vaccine Advisory Committee News

New Vaccine Advisory Committee recommendations and guidance for meningococcal conjugate vaccine

At its quarterly meeting on April 21, 2011, the Vaccine Advisory Committee unanimously voted to recommend full acceptance of the Advisory Committee for Immunization Practices’ recommendations for use of meningococcal conjugate vaccines as published on January 28, 2011, in the Morbidity and Mortality Weekly Report. In general, the new recommendations call for a booster dose at age 16 years. A booster dose is not required if the first dose is given after the patient’s 16th birthday.

The committee recognizes that creating opportunities to vaccinate adolescents is more challenging than younger kids and infants. The committee has also included clinical-level guidance to providers regarding this issue.

To read the recommendation and guidance visit our Current Recommendations page.
 

Last Update : 07/29/2011 03:27 PM